MENU
+Compare
SYNB
ETF ticker: NYSE ARCA
AS OF
Sep 3, 04:55 PM (EDT)
Price
$30.21
Change
-$0.06 (-0.20%)
Net Assets
5.32M

SYNB stock forecast, quote, news & analysis

The investment seeks long term capital appreciation... Show more

Category: #Health
SYNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SYNB with price predictions
Sep 02, 2025

SYNB sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for SYNB moved above the 200-day moving average on September 02, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 13, 2025. You may want to consider a long position or call options on SYNB as a result. In of 47 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SYNB just turned positive on August 27, 2025. Looking at past instances where SYNB's MACD turned positive, the stock continued to rise in of 23 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 135 cases where SYNB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

SYNB broke above its upper Bollinger Band on August 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Alphabet (NASDAQ:GOOGL), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), ZOETIS (NYSE:ZTS), Regeneron Pharmaceuticals (NASDAQ:REGN), DuPont de Nemours (NYSE:DD), Biogen (NASDAQ:BIIB), Exact Sciences Corp (NASDAQ:EXAS).

Industry description

The investment seeks long term capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on “biology revolution” companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.

Market Cap

The average market capitalization across the Putnam BioRevolution ETF ETF is 227.72B. The market cap for tickers in the group ranges from 349.61M to 4.16T. NVDA holds the highest valuation in this group at 4.16T. The lowest valued company is RCKT at 349.61M.

High and low price notable news

The average weekly price growth across all stocks in the Putnam BioRevolution ETF ETF was 11%. For the same ETF, the average monthly price growth was 42%, and the average quarterly price growth was 83%. EXAS experienced the highest price growth at 4%, while NVDA experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Putnam BioRevolution ETF ETF was 8%. For the same stocks of the ETF, the average monthly volume growth was 6% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 71
Price Growth Rating: 53
SMR Rating: 68
Profit Risk Rating: 68
Seasonality Score: -37 (-100 ... +100)
View a ticker or compare two or three
SYNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Putnam ETF Trus100 FEDERAL STREET
Phone
6177601060
Web
N/A